TheProfitWatch

CUE - Cue Biopharma, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.54 0.06 (11.63%) --- --- 0.02 (3.02%) 0.0 (0.0%) 0.06 (11.8%) 0.02 (2.9%) 0.0 (-0.28%)

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-6.7078
Diluted P/E:
-6.7078
RSI(14) 1m:
61.07
VWAP:
0.6
RVol:

Events

Period Kind Movement Occurred At

Related News